On April 24, 2025, at the 2025 Annual Meeting, Avanos Medical, Inc. reported that shareholders elected five directors, approved auditor appointment, executive compensation, and increased shares in their incentive plan, with about 93.64% of shares represented. Key votes included 36 million votes for director Gary D. Blackford and 40 million for auditor Deloitte & Touche.